Literature DB >> 24685624

Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.

Gad A Marshall1, Natacha Lorius1, Joseph J Locascio2, Bradley T Hyman2, Dorene M Rentz1, Keith A Johnson3, Reisa A Sperling1.   

Abstract

BACKGROUND: Impairment in instrumental activities of daily living (IADL) heralds the transition from mild cognitive impairment (MCI) to dementia and is a major source of burden for both the patient and caregiver.
OBJECTIVE: To investigate the relationship between IADL and regional cortical thinning and cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers cross-sectionally and longitudinally in clinically normal (CN) elderly, MCI, and mild AD dementia subjects.
METHODS: Two hundred and twenty nine CN, 395 MCI, and 188 AD dementia subjects participating in the Alzheimer's Disease Neuroimaging Initiative underwent baseline magnetic resonance imaging, baseline lumbar puncture, and clinical assessments, including the Functional Activities Questionnaire used to measure IADL, every 6 to 12 months up to 3 years. General linear regression and mixed effects models were employed.
RESULTS: IADL impairment was associated with the interactions between lower inferior temporal cortical thickness and diagnosis (p < 0.0001), greater lateral occipital cortical thickness and diagnosis (p < 0.0001), and greater amyloid-β 1-42 (Aβ1-42) and diagnosis (p = 0.0002) at baseline (driven by AD dementia). Lower baseline supramarginal (p = 0.02) and inferior temporal (p = 0.05) cortical thickness, lower Aβ1-42 (p < 0.0001), and greater total tau (t-tau) (p = 0.02) were associated with greater rate of IADL impairment over time.
CONCLUSIONS: Temporal atrophy is associated with IADL impairment in mild AD dementia at baseline, while baseline parietal and temporal atrophy, lower CSF Aβ1-42, and greater t-tau predict worsening IADL impairment over time across the AD spectrum. These results emphasize the importance of assessing IADL at the stage of MCI and even at the transition from CN to MCI.

Entities:  

Keywords:  Alzheimer's disease; cerebrospinal fluid; instrumental activities of daily living; magnetic resonance imaging; mild cognitive impairment

Mesh:

Substances:

Year:  2014        PMID: 24685624      PMCID: PMC4111766          DOI: 10.3233/JAD-132768

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

1.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Authors:  Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

2.  Incidence of dementia in a community-dwelling Brazilian population.

Authors:  R Nitrini; P Caramelli; E Herrera; V S Bahia; L F Caixeta; M Radanovic; R Anghinah; H Charchat-Fichman; C S Porto; M T Carthery; A P J Hartmann; N Huang; J Smid; E P Lima; L T Takada; D Y Takahashi
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

3.  Regulatory innovation and drug development for early-stage Alzheimer's disease.

Authors:  Nicholas Kozauer; Russell Katz
Journal:  N Engl J Med       Date:  2013-03-13       Impact factor: 91.245

4.  Functional deficits in patients with mild cognitive impairment: prediction of AD.

Authors:  M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

5.  Cerebral metabolic correlates of four dementia scales in Alzheimer's disease.

Authors:  E Salmon; S Lespagnard; P Marique; F Peeters; K Herholz; D Perani; V Holthoff; E Kalbe; D Anchisi; S Adam; F Collette; G Garraux
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

6.  Measurement of functional activities in older adults in the community.

Authors:  R I Pfeffer; T T Kurosaki; C H Harrah; J M Chance; S Filos
Journal:  J Gerontol       Date:  1982-05

7.  Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

Authors:  Annika Olsson; Hugo Vanderstichele; Niels Andreasen; Geert De Meyer; Anders Wallin; Björn Holmberg; Lars Rosengren; Eugeen Vanmechelen; Kaj Blennow
Journal:  Clin Chem       Date:  2004-11-24       Impact factor: 8.327

8.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

9.  Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

Authors:  Tero Tapiola; Irina Alafuzoff; Sanna-Kaisa Herukka; Laura Parkkinen; Päivi Hartikainen; Hilkka Soininen; Tuula Pirttilä
Journal:  Arch Neurol       Date:  2009-03

10.  Neuropathologic correlates of activities of daily living in Alzheimer disease.

Authors:  Gad A Marshall; Lynn A Fairbanks; Sibel Tekin; Harry V Vinters; Jeffrey L Cummings
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Jan-Mar       Impact factor: 2.703

View more
  33 in total

1.  Validation of online functional measures in cognitively impaired older adults.

Authors:  Rachel L Nosheny; Monica R Camacho; Chengshi Jin; John Neuhaus; Diana Truran; Derek Flenniken; Miriam Ashford; Maria C Carrillo; Keith N Fargo; James Hendrix; Lucy Hanna; Gil Rabinovici; Paul Maruff; R Scott Mackin; Michael W Weiner
Journal:  Alzheimers Dement       Date:  2020-07-27       Impact factor: 21.566

2.  Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.

Authors:  Maria Vassilaki; Jeremiah A Aakre; Walter K Kremers; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Preciosa M Coloma; Barbara Schauble; Prashanthi Vemuri; Val J Lowe; Clifford R Jack; Ronald C Petersen; Rosebud O Roberts
Journal:  J Am Geriatr Soc       Date:  2018-11-21       Impact factor: 5.562

3.  Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairment.

Authors:  Gad A Marshall; Amy S Zoller; Kathleen E Kelly; Rebecca E Amariglio; Joseph J Locascio; Keith A Johnson; Reisa A Sperling; Dorene M Rentz
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

Review 4.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

5.  Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.

Authors:  Christopher Gonzalez; Nicole S Tommasi; Danielle Briggs; Michael J Properzi; Rebecca E Amariglio; Gad A Marshall
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Classification of MRI and psychological testing data based on support vector machine.

Authors:  Wenlu Yang; Xinyun Chen; David S Cohen; Eric R Rosin; Arthur W Toga; Paul M Thompson; Xudong Huang
Journal:  Int J Clin Exp Med       Date:  2017-12

7.  SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment.

Authors:  Amy S Zoller; Ildiko M Gaal; Christine A Royer; Joseph J Locascio; Rebecca E Amariglio; Deborah Blacker; Olivia I Okereke; Keith A Johnson; Reisa A Sperling; Dorene M Rentz; Gad A Marshall
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

8.  Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.

Authors:  Gad A Marshall; Jennifer R Gatchel; Nancy J Donovan; Martha C Muniz; Aaron P Schultz; J Alex Becker; Jasmeer P Chhatwal; Bernard J Hanseeuw; Kathryn V Papp; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

9.  Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is Correlated with Premorbid Intelligence, Clinical Stage, and Alzheimer's Disease Biomarkers.

Authors:  Anna Malishkevich; Gad A Marshall; Aaron P Schultz; Reisa A Sperling; Judith Aharon-Peretz; Illana Gozes
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

10.  Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.

Authors:  Bernard J Hanseeuw; Aaron P Schultz; Rebecca A Betensky; Reisa A Sperling; Keith A Johnson
Journal:  Alzheimers Dement       Date:  2016-07-13       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.